This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Little evidence for benefit of interventions in the early stage of chronic kidney disease
Research Activities, March 2012, No. 379
A new research review from the Agency for Healthcare Research and Quality (AHRQ) found no or limited evidence that interventions are beneficial to patients in the early stages of chronic kidney disease. The report evaluated the evidence regarding the potential benefits and harms of screening, monitoring, and treatment of adults in stage 1, 2, or 3 of the five stages of chronic kidney disease. The report authors noted that many knowledge gaps remain, and additional research should increase understanding about optimal approaches to chronic kidney disease screening, monitoring, and treatment. Chronic kidney disease affects more than 44 percent of U.S. adults over the age of 70.
Internet Citation: Little evidence for benefit of interventions in the early stage of chronic kidney disease: Research Activities, March 2012, No. 379.
March 2012. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/newsletters/research-activities/mar12/0312RA23.html
The information on this page is archived and provided for reference purposes only.